Brett Swansiger

Brett Swansiger is Chief Commercial Officer for ANGLE, and is responsible for managing pharma and clinical services sales and building corporate partnerships globally, and for guiding US research and clinical sales and payer engagement. He also supports the products business teams responsible for sale of products via direct sales and through distributors.

Brett has over 20 years of commercial leadership, international business development, business to business sales, and U.S. managed care contracting experience within the molecular diagnostics and pharmaceutical industries. Brett started his career within the life science industry back in 1998 working for Bristol Myers Squibb in their neuroscience and infectious disease division. After departing Bristol Myers Squibb, Brett joined a startup specialty diagnostic and pharmaceutical company, Prometheus Laboratories, where he held multiple commercial positions over his 12-year tenure, responsible for sales training, field sales leadership, and payer engagement.

In 2013 Brett was recruited by Agendia Inc., a Netherlands-based start-up, to build out their US payer engagement and Asia market access strategies, responsible for implementing positive medical policies, payer contracts with all major US payers, and executing distribution agreements throughout SE Asia. Then in 2016, Brett was recruited by MDxHealth, a multinational esoteric urologic oncology laboratory where he was again responsible for building out their US payer engagement strategy. During his five-year tenure, Brett held numerous commercial leadership positions including VP Managed Care and Strategic Accounts, SVP Business Development and European Sales, Interim CCO, and SVP of US Sales and Business Development.

Most recently, Brett was CCO at DxTerity Diagnostics, a Los Angeles based precision medicine company pioneering the use of RNA-based precision medicine where he was responsible for building out DxTerity commercial organization, business-to-business, and payer strategies.

Throughout his career Brett managed sales organizations in both the US and Europe, has launched over 20 proprietary specialty diagnostic assays, executed 12 international market deals, executed 100+ US payer contracts, and over 200 business to business clinical testing service contracts.

Brett is a U.S. Army Veteran, having served as a member of the 1st Battalion 12th Field Artillery on both active duty and as a member of the US Army reserve. Brett volunteers his time with multiple veteran charities and mentoring university business students.